eHealthStore was created through CPM’s strategic alliance with Retailigence, a leading platform connecting marketers with a nationwide shopper audience on the path-to-purchase. Through this new development, CPM now
IMO-2125 is a TLR9 agonist that was assessed subcutaneously in around 80 human subjects. It was well tolerated and demonstrated to induce immune responses. Idera Pharmaceuticals CEO Vincent
The fruit punch tablets are the latest product in the line of the company’s performance energy offerings, and currently available at several sports specialty retail stores across the
The acquisition will create a broad portfolio of commercial products and also position Pozen to expand its foreign presence through potential international sales and licensing, manufacturing and product
TX-004HR is an investigational bio-identical estradiol softgel capsule that can be administered vaginally without the need for an applicator. The pivotal safety and efficacy Rejoice trial is a
As part of ‘Make in India’ initiative, Bharat Immunologicals and Biologicals Corporation (BIBCOL) will develop Measles – Rubella vaccine at its plant at Chola, Bulandshahr, Uttar Pradesh, India.
The deal amount will be paid by Cardinal using existing cash and new debt. The acquisition is expected to complete in the beginning of fiscal year 2016 after
In Europe, Resolor is approved for use in women, and so the new variation extends the use of this treatment to male patients. It is estimated that about
Manufactured by 3M Drug Delivery Systems, it is claimed to be the first bioequivalent alternative for GlaxoSmithKline’s Seretide Evohaler (salmeterol xinafoate/fluticasone propionate). It can be used for the
With the submission, the company looks to treat multiple myeloma patients who have received at least three prior lines of therapy, including a proteasome inhibitor (PI) and an
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.